Viamet Appoints Dr. Volker Herrmann As Chief Commercial Officer

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc. today announced the appointment of Volker Herrmann, M.D., M.B.A., as Chief Commercial Officer. Dr. Hermann is an accomplished pharmaceutical executive with extensive experience in sales, marketing, commercial strategy and market access. Prior to joining Viamet, Dr. Herrmann served as Head of Global Strategy, Commercial Development & Global Marketing for the Vaccines Business Unit of Pfizer Inc. At Pfizer, he contributed to the successful performance of several of the most significant brands in the pharmaceutical marketplace.

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.